Securities

  • November 04, 2026

    Fintechs Prepare For Blue Wave's Flood Of Investigations

    Democrats rode Tuesday night's blue wave to take control of both chambers of Congress, scuttling the legislative hopes of a crypto industry that's now battening down the hatches for a flood of investigations into its ties to the Trump administration, consumer protection and financial crime.

  • November 04, 2026

    OCC Maps Out How Its Examiners Will Review Banks' AI Use

    The use of artificial intelligence at banks to conduct payments, decide loan applications or perform other high-stakes activities autonomously could face closer examiner scrutiny under a new supervisory framework issued Wednesday by the Office of the Comptroller of the Currency.

  • November 04, 2026

    Colo. Says Radiologist's AI Fund Was A Ponzi-Like Scheme

    Colorado's securities commissioner accused a Lakewood radiologist and his investment company of fraudulently raising about $5.2 million from 14 investors, including his parents and brothers, by touting an artificial intelligence trading program that was in fact an untested work in progress that lost money nearly every month.

  • November 04, 2026

    Meta Share Plan Fight Gets January Injunction Hearing

    The Delaware Chancery Court ruled Wednesday that stockholders challenging Meta Platforms Inc.'s plan to create nonvoting shares will get a preliminary injunction hearing in early January, rejecting the company's push for a full trial before the transaction takes effect Jan. 19, 2027.

  • November 04, 2026

    Judge Says CFTC Likely Overstepped On Stock Perpetuals

    A New York federal judge said the U.S. Commodity Futures Trading Commission likely exceeded its authority when it signed off on the trading of perpetual contracts tied to individual stocks, but stopped short of hitting it with a temporary restraining order in a suit brought by a special interest organization backed by Cboe Global Markets Inc.

  • November 04, 2026

    Walgreens Seeks Sanctions In Investors' Pharma Growth Suit

    Walgreens has asked an Illinois federal judge to sanction investors and their attorneys in a securities fraud class action, arguing they continued to falsely attribute statements about the company's plans to open hundreds of clinics to a former executive even after a recording showed his statement was taken out of context.

  • November 04, 2026

    4 Argument Sessions For Benefits Attys To Watch In Nov.

    JPMorgan Chase & Co. will defend its win in a 401(k) forfeiture suit at the Ninth Circuit, Aetna will ask the Second Circuit to push a multiemployer health plan's suit into arbitration, and the Tenth Circuit hears from pharmacy benefit managers who want an opioid nuisance battle moved to federal court. Here, Law360 looks at four arguments that benefits attorneys may want to keep an eye on in November.

  • November 04, 2026

    1st Circ. Sees Mass. Promise To Robinhood As 'Cold Comfort'

    First Circuit judges on Wednesday appeared sympathetic to Robinhood's bid to have a federal court determine if Massachusetts can regulate prediction markets, with two judges calling the state's temporary promise not to sue the fintech platform "cold comfort." 

  • November 04, 2026

    9th Circ. Won't Rehear Kalshi's Nevada Sports Betting Fight

    The Ninth Circuit on Wednesday rejected Kalshi's request to rehear its dispute with the state of Nevada, following a panel decision that cleared the way for the state's gaming regulators to pursue the prediction market platform over its sports event contracts.

  • November 04, 2026

    SEC Classifies More Funds, Advisers As 'Small Entities'

    The U.S. Securities and Exchange Commission on Wednesday adopted regulations that designate more mutual funds and investment advisers as small entities in order to "eliminate unnecessary regulatory burdens," SEC Chairman Paul Atkins said.

  • November 04, 2026

    Lender Says Del. Court Wrongly Voided $20M Loan Liens

    A lender urged the Delaware Supreme Court on Wednesday to revive its claim to $20.4 million in security interests tied to loans to collapsed technology company Bitwise Industries, saying a contract protected it even if the company's executives lacked authority to pledge real estate as collateral.

  • November 04, 2026

    Krispy Kreme Brass Face Another Suit Over McDonald's Deal

    More Krispy Kreme shareholders have filed suit in North Carolina federal court against current and former executives over alleged misrepresentations of the doughnut company's aborted rollout of a partnership with McDonald's.

  • November 03, 2026

    Justin Sun Says Trump-Tied Crypto Firm Deserves Sanctions

    Billionaire Justin Sun urged a California federal judge to sanction World Liberty Financial in litigation over his $45 million investment in the Trump-tied crypto firm, saying the company cost him hundreds of thousands of dollars when it "violated one of the most basic requirements" of the court.

  • November 03, 2026

    States, Others Back Argentina Sovereign Immunity Challenge

    Fourteen states, a U.S. senator from Missouri and others are urging the U.S. Supreme Court to reverse a Second Circuit decision overturning a New York judge's $16 billion judgment against Argentina in a case that arose from its nationalization of YPF SA, the country's largest oil and gas exploration company.

  • November 03, 2026

    Block Seeks $764M Deal To End DOJ Cash App Fraud Probe

    Jack Dorsey's Block Inc. revealed in an investor filing Tuesday it has reached a tentative deal to resolve a U.S. Department of Justice investigation into claims that it ignored fraud on its Cash App, outlining terms that include a deferred prosecution agreement and payment of more than $760 million.

  • November 03, 2026

    Blood Vessel Maker Strikes $9M Deal To End Investor Action

    Biotechnology company Humacyte Inc. and a proposed class of investors have reached a $9 million deal to end claims that the company failed to disclose quality assurance issues at its manufacturing facilities that allegedly delayed regulatory review for its bioengineered blood vessel product candidate, leading to stock price declines.

  • November 03, 2026

    Asia-Based Accountants Say PCAOB Overstepped Authority

    The Public Company Accounting Oversight Board has violated limits Congress placed on it by requiring three accountants to fly to Washington, D.C., on their own dime from their Southeast Asia homes to comply with certain board demands or face sanctions, according to a lawsuit filed Tuesday in D.C. federal court.

  • November 03, 2026

    2nd Circ. Denies Kalshi, Coinbase Enforcement Shields

    A Second Circuit panel on Tuesday rebuffed separate bids by Kalshi and Coinbase to temporarily shield their sports contracts from New York and Connecticut gambling regulators after the judges appeared unconvinced by the platforms' attempts to draw lines between sports event contracts and sports bets.

  • November 03, 2026

    Colo. Company Accused Of Improperly Collecting Legal Fees

    A Colorado company that purports to get customer disputes expunged from Financial Industry Regulatory Authority unlawfully collects legal fees for its services while claiming not to be a law firm, an Illinois financial adviser said in Colorado state court Friday.

  • November 03, 2026

    Rivian Brass Reaches Deal To End Post-IPO Price Hike Suit

    Rivian Automotive Inc. executives and the company's investors Tuesday filed a notice telling a California federal court they reached a settlement to end derivative claims Rivian hid the true price of manufacturing its electric vehicles ahead of its initial public offering.

  • November 03, 2026

    SEC Says Guilty Plea Proves CEO's Stock Fraud Scheme

    A Seattle federal court should find that a former cannabis company CEO committed securities fraud, the U.S. Securities and Exchange Commission said, arguing his guilty plea and criminal conviction for pump-and-dump schemes and lying to investors should settle the matter.

  • November 03, 2026

    Chancery Ends Icahn Suit Over Illumina's $8B Grail Deal

    The Delaware Chancery Court has approved the dismissal of a lawsuit brought by affiliates of activist investor Carl Icahn against Illumina Inc.'s former directors over the biotechnology company's $8 billion acquisition of Grail Inc., ending the case under a settlement that does not bind other stockholders.

  • November 03, 2026

    PCAOB Floats Change That Could Aid Semiannual Reporting

    The Public Company Accounting Oversight Board Tuesday proposed a rule change that could make it easier for companies to raise capital should they decide to switch to a semiannual reporting schedule.

  • November 03, 2026

    CFTC Sued As It Allows Single-Stock Perp Contracts Trading

    The U.S. Commodity Futures Trading Commission on Tuesday signed off on the trading of perpetual contracts tied to individual stocks and was almost immediately sued by a special interest organization backed by Cboe Global Markets Inc. and others accusing the agency of putting investors at risk.

  • November 03, 2026

    Squires Grants 4 IPRs, Denies 6 Before Handing Over Power

    U.S. Patent and Trademark Office Director John Squires on Tuesday instituted four inter partes reviews in what could be the final petitions for which he reviews the merits.

Expert Analysis

  • Bribery Verdict Offers Guide To Post-Pause FCPA Priorities

    Author Photo

    A former Goldman Sachs investment banker's recent Foreign Corrupt Practices Act conviction offers insights into how the U.S. Department of Justice is applying its FCPA guidelines following the Trump administration's 2025 pause on enforcement, and illustrates the importance of a company’s escalation procedures and follow-through, say attorneys at Debevoise.

  • 3rd Circ. Ruling Opens Door For Fraud-On-The-Market Rethink

    Author Photo

    The Third Circuit's recent decision in Ocugen, holding that a stable stock price after publication of restated financials does not prove immateriality, could be a vehicle for the U.S. Supreme Court to overturn the doctrine undergirding certification of securities class actions, says Jonathan Richman at Brown Rudnick.

  • Opinion

    The SEC Crypto Proposal Rests On A Term No One Can Define

    Author Photo

    The U.S. Securities and Exchange Commission's recently proposed Regulation Crypto Assets is its most ambitious attempt to set rules for the crypto industry, but its repeated use of the phrase "essential managerial efforts" means it perpetuates the uncertainty the regime is meant to cure, says Joseph A. Hall at Davis Polk.

  • Navigating Dueling Regulations For Bank Investment Advisers

    Author Photo

    Recent U.S. Securities and Exchange Commission examination findings show that investment advisory activities remain an active area of regulatory focus, and reinforce the need for banks to assess intersecting compliance obligations, say attorneys at Fredrikson.

  • Series

    Being In The Peace Corps Made Me A Better Lawyer

    Author Photo

    When I served in the Peace Corps, the people of the West African village where I was stationed helped me acclimate to my new surroundings and enabled me to develop problem-solving, teamwork and empathy skills that have bolstered my legal practice far beyond the ability to offer technical advice, says Brian Bewley at McGuireWoods.

  • Measuring Shareholder Harm In Death Spiral Convertibles

    Author Photo

    As convertible structures have recently regained prominence, it's important to revisit the so-called floating-price death spiral convertible and how to quantify the losses for shareholders when disputes arise, says Pavithra Kumar at Conexig.

  • Unpacking FDIC's Modernized Bank Merger Review Rules

    Author Photo

    The Federal Deposit Insurance Corp.'s proposed revisions to its Bank Merger Act review process are a shift from its more skeptical prior posture toward a more structured and transaction-facilitative approach, though some broader uncertainty remains concerning antitrust alignment with the U.S. Department of Justice, say attorneys at Simpson Thacher.

  • White House AI Accord Could Reshape Reasonable Care

    Author Photo

    President Donald Trump's recent joint commitment on frontier responsibilities — signed by leaders of Google, Anthropic, Meta and more — may pose legal risks for nonsignatories, as businesses using artificial intelligence may find the accord's safeguards cited against them as evidence of what reasonable care requires, says Peter Schildkraut at Arnold & Porter.

  • Del. Ruling Shows How AI Meeting Transcripts Can Backfire

    Author Photo

    In ATG Capital Opportunities Fund v. Lane, the Delaware Court of Chancery reviewed board meeting transcripts generated by an artificial intelligence tool as part of its assessment of the board's motivations, highlighting potential risks of AI-generated corporate records, say attorneys at Debevoise.

  • Dissecting Dodd's, Gensler's Prediction Market Amicus Briefs

    Author Photo

    Former Sen. Chris Dodd and former U.S. Commodity Futures Trading Commission Chairman Gary Gensler's recent amicus briefs in support of New Jersey's petition for U.S. Supreme Court review of Kalshi v. Flaherty draw on legislative history to counter the CFTC's claim of federal preemption over the prediction markets, says Trace Schmeltz at Steptoe.

  • OCC Plan May Bring Data Sharing Flexibility, Diligence Issues

    Author Photo

    The Office of the Comptroller of the Currency's recent proposal to overhaul its supervisory information sharing regime for the first time in decades would provide important flexibility to banks, but it could create new issues around confidentiality agreements, disclosure controls and diligence processes, say attorneys at Simpson Thacher.

  • 5 Prediction Market Queries For Every League, Athletic Dept.

    Author Photo

    The NFL's recent amicus brief urging the U.S. Supreme Court to resolve a circuit split over regulating prediction markets and operators like Kalshi raises important, enterprisewide governance questions for leagues, teams and athletic departments, and highlights that regulatory oversight and institutional integrity are related but distinct, say attorneys at Robins Kaplan.

  • Planning For D&O Exclusions As Risks Mount For Banks

    Author Photo

    Banks should scrutinize directors and officers exclusions for artificial intelligence, disclosure and cybersecurity risks during policy renewal negotiations to preserve coverage amid the current uptick in insurer scrutiny and related shareholder litigation, say attorneys at Jones Walker.

  • Why The SEC Proposed Rescinding Its 'Pay-To-Play' Rule

    Author Photo

    The U.S. Securities and Exchange Commission's recent proposal to nix its pay-to-play rule governing political contributions by investment advisers follows years of industry advocacy and commissioner criticism that it suppresses political speech and affects hiring, say attorneys at Simpson Thacher.

  • SEC's Insider Trading Duty Rule May Face Loper Bright Test

    Author Photo

    In U.S. v. Jennings, pending in New Jersey federal court, the defense has an opportunity to challenge the rule defining the boundaries of the misappropriation theory of insider trading under Loper Bright, as the only litigated case testing the rule's limits relied on Chevron deference, say attorneys at O'Melveny.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Securities archive.